Ligands
No highly selective agonists or antagonists for the M5 receptor have been discovered as of 2018, but several non-selective muscarinic agonists and antagonists have significant affinity for M5. The lack of selective M5 receptor ligands is one of the main reasons that the medical community has such a limited understanding of the M5 receptors effects as the possibility that any and/or all effects of non-selective ligands may be due to interactions with other receptors can not be ruled out. Some data may be obtained by observing which effects are common among semi-selective ligands (ex. a ligand of M1 and M5, a ligand of M2 and M5, and a ligand of M3 and M5), but until both a selective agonist and a selective antagonist of the M5 receptor are developed this data must be considered merely theoretical.Agonists
* Acetylcholine * Bethanechol * Methacholine * Milameline ((E)-1,2,5,6-Tetrahydro-1-methyl-3-pyridinecarboxaldehyde-O-methyloxime, CAS# 139886-32-1) * PilocarpinePositive allosteric modulators
* ML-380 * ML-326 * VU-0238429: EC50 = 1.16 μM; >30-fold selectivity versus M1 and M3, inactive at M2 and M4.Negative allosteric modulators
* ML375 *VU6008667Antagonists
* VU-0488130 (ML381) * VU6036864 * Xanomeline *See also
* Muscarinic acetylcholine receptorReferences
Further reading
* * * * * * * * * * * * * * * {{DEFAULTSORT:Muscarinic Acetylcholine Receptor M5 G protein-coupled receptors Human proteins Muscarinic acetylcholine receptors